Author:
Cochran Hunter C,Pandey Yadav,Nicholas Richard W.,Del Giacco Eric J.,Mazin Safar A.
Reference17 articles.
1. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment;Duma;Mayo Clin. Proc.,2019
2. Immunotherapy in lung cancer: a new age in cancer treatment;Corrales;Adv. Exp. Med. Biol.,2018
3. Long-term survival in patients (pts) with advanced NSCLC in the KEYNOTE-010 study overall and in pts who completed two years of pembrolizumab (pembro);Herbst;Ann. Oncol.,2018
4. Therapy for Stage IV non-small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update;Hanna;J. Clin. Oncol.,2020
5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE- 010): a randomised controlled trial;Herbst;Lancet,2016